Skip to main content

IL-22 blocker investigated in phase 2a atopic dermatitis study

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
IL-22 blocker investigated in phase 2a atopic dermatitis study

User login

Username

Password

Reset your password

Type	Lead	score